News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
232,051 Results
Type
Article (5092)
Company Profile (24)
Press Release (226935)
Multimedia
Podcasts (2)
Webinars (4)
Section
Business (82256)
Career Advice (463)
Deals (15056)
Drug Delivery (8)
Drug Development (19077)
Employer Resources (30)
FDA (3683)
Job Trends (3910)
News (120192)
Policy (7516)
Tag
2027 Genetown Elite (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (2)
Academia (293)
Accelerated approval (6)
Adcomms (4)
Allergies (14)
Alliances (14809)
ALS (38)
Alzheimer's disease (294)
Antibody-drug conjugate (ADC) (40)
Approvals (3783)
Artificial intelligence (80)
Autoimmune disease (27)
Automation (5)
Bankruptcy (97)
Best Places to Work (2865)
Biosimilars (32)
Biotechnology (23)
Bladder cancer (34)
Brain cancer (7)
Breast cancer (101)
Cancer (886)
Cardiovascular disease (61)
Career advice (395)
Career pathing (3)
CAR-T (64)
CDC (2)
Cell therapy (166)
Cervical cancer (5)
Clinical research (16684)
Collaboration (353)
Compensation (371)
Complete response letters (8)
COVID-19 (313)
CRISPR (13)
C-suite (339)
Cystic fibrosis (28)
Data (1325)
Denatured (1)
Depression (21)
Diabetes (78)
Diagnostics (2119)
Digital health (7)
Diversity (1)
Diversity, equity & inclusion (13)
Drug discovery (31)
Drug pricing (14)
Drug shortages (2)
Duchenne muscular dystrophy (35)
Earnings (42737)
Editorial (5)
Employer branding (6)
Employer resources (32)
Events (39139)
Executive appointments (424)
FDA (4421)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (4)
Frontotemporal dementia (8)
Funding (340)
Gene editing (24)
Generative AI (5)
Gene therapy (102)
GLP-1 (144)
Government (424)
Guidances (197)
Healthcare (5049)
HIV (10)
Huntington's disease (5)
IgA nephropathy (11)
Immunology and inflammation (39)
Immuno-oncology (7)
Indications (16)
Infectious disease (339)
Inflammatory bowel disease (36)
Inflation Reduction Act (3)
Influenza (6)
Intellectual property (32)
Interviews (53)
IPO (7880)
IRA (3)
Job creations (1123)
Job search strategy (361)
JPM (4)
Kidney cancer (10)
Labor market (10)
Layoffs (106)
Leadership (5)
Legal (2337)
Liver cancer (21)
Longevity (2)
Lung cancer (92)
Lymphoma (70)
Machine learning (3)
Management (10)
Manufacturing (139)
MASH (50)
Medical device (3921)
Medtech (3931)
Mergers & acquisitions (7581)
Metabolic disorders (214)
Multiple sclerosis (18)
NASH (6)
Neurodegenerative disease (54)
Neuropsychiatric disorders (12)
Neuroscience (539)
NextGen: Class of 2026 (1674)
Non-profit (730)
Now hiring (5)
Obesity (84)
Opinion (32)
Ovarian cancer (26)
Pain (26)
Pancreatic cancer (38)
Parkinson's disease (50)
Partnered (6)
Patents (51)
Patient recruitment (96)
Peanut (6)
People (25226)
Pharmaceutical (7)
Pharmacy benefit managers (2)
Phase 1 (4996)
Phase 2 (7226)
Phase 3 (5789)
Pipeline (1962)
Policy (17)
Postmarket research (625)
Preclinical (1948)
Press Release (66)
Prostate cancer (57)
Psychedelics (3)
Radiopharmaceuticals (109)
Rare diseases (179)
Real estate (1886)
Recruiting (8)
Regulatory (5539)
Reports (17)
Research institute (308)
Resumes & cover letters (69)
Rett syndrome (19)
RNA editing (1)
RSV (2)
Schizophrenia (49)
Series A (53)
Series B (54)
Sickle cell disease (10)
Special edition (1)
Spinal muscular atrophy (33)
Sponsored (5)
Startups (1018)
Stomach cancer (1)
Supply chain (13)
Tariffs (7)
The Weekly (1)
Vaccines (80)
Venture capital (9)
Weight loss (29)
Women's health (6)
Date
Today (4)
Last 7 days (147)
Last 30 days (648)
Last 365 days (8908)
2026 (786)
2025 (9036)
2024 (11030)
2023 (13194)
2022 (18669)
2021 (19682)
2020 (18252)
2019 (13206)
2018 (10205)
2017 (10003)
2016 (9159)
2015 (12119)
2014 (9589)
2013 (7709)
2012 (8329)
2011 (8797)
2010 (8637)
Location
Africa (186)
Alabama (19)
Alaska (2)
Arizona (74)
Arkansas (1)
Asia (11783)
Australia (1690)
California (3541)
Canada (1139)
China (167)
Colorado (143)
Connecticut (162)
Delaware (70)
Europe (25489)
Florida (541)
Georgia (67)
Idaho (24)
Illinois (161)
India (14)
Indiana (105)
Iowa (9)
Japan (164)
Kansas (36)
Kentucky (17)
Louisiana (8)
Maine (51)
Maryland (352)
Massachusetts (2803)
Michigan (104)
Minnesota (201)
Mississippi (1)
Missouri (31)
Montana (17)
Nebraska (12)
Nevada (46)
New Hampshire (16)
New Jersey (1018)
New Mexico (5)
New York (814)
North Carolina (479)
North Dakota (4)
Northern California (1854)
Ohio (117)
Oklahoma (5)
Oregon (6)
Pennsylvania (597)
Puerto Rico (1)
Rhode Island (19)
South America (279)
South Carolina (17)
Southern California (1304)
Tennessee (61)
Texas (480)
United States (12329)
Utah (111)
Virginia (84)
Washington D.C. (17)
Washington State (297)
West Virginia (2)
Wisconsin (57)
Wyoming (1)
232,051 Results for "quidel corporation".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
QuidelOrtho to Report Fourth Quarter and Full-Year 2025 Financial Results
January 21, 2026
·
1 min read
Press Releases
QuidelOrtho Welcomes Erich Wolff as Executive Vice President, Strategy & Corporate Development
August 20, 2025
·
3 min read
Press Releases
QuidelOrtho To Participate In Upcoming December 2025 Investor Conferences
November 24, 2025
·
1 min read
Press Releases
QuidelOrtho Receives FDA 510(k) Clearance for VITROS™ Immunodiagnostic Products hs Troponin I Assay
November 4, 2025
·
3 min read
Press Releases
QuidelOrtho to Report Third Quarter 2025 Financial Results
October 23, 2025
·
1 min read
Biotech Beach
QuidelOrtho Receives Health Canada Approval for Quidel® Triage® PLGF Test for Laboratory Use in Canada
QuidelOrtho Corporation (Nasdaq:QDEL) (“QuidelOrtho”), a global provider of innovative in vitro diagnostic technologies designed for point-of-care settings, clinical labs and transfusion medicine, has received approval from Health Canada for its Triage PLGF test for laboratory use in Canada.
March 6, 2024
·
4 min read
Deals
Quidel Announces Stockholder Approval of Ortho Acquisition and Business Combination
Quidel Corporation announced that the previously announced acquisition of Ortho Clinical Diagnostics Holdings plc by Quidel and subsequent business combination were approved by Quidel’s stockholders at Quidel’s Special Meeting on May 16, 2022.
May 16, 2022
·
6 min read
Deals
Quidel Corporation Signs Definitive Agreement to Acquire Ortho Clinical Diagnostics
Quidel Corporation today announced that they have entered into a definitive agreement in which Quidel will acquire Ortho.
December 23, 2021
·
15 min read
Press Releases
QuidelOrtho Reports Third Quarter 2025 Financial Results
November 5, 2025
·
20 min read
Biotech Beach
Quidel’s Antigen Tests Detect the Omicron Variant
Quidel Corporation (NASDAQ: QDEL) (“Quidel”), a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, issued the following statement from Douglas Bryant, Quidel’s President and CEO, regarding Quidel’s ongoing efforts to evaluate COVID-19 mutations and confirm that its antigen tests continue to detect COVID-19 variants such as Omicron.
December 28, 2021
·
4 min read
1 of 23,206
Next
